Markets

POET Technologies: After a Volatile Week, What Lies Ahead?

POET Technologies shares fell 7.3% on Friday to $12.29, capping a week of nearly 16% decline, while the Nasdaq rose 2.4%. The company raised $400M in a direct offering but faces lawsuits and uncertainty after losing Celestial AI orders.

Daniel Marsh · · · 3 min read · 0 views
POET Technologies: After a Volatile Week, What Lies Ahead?
Mentioned in this article
POET $12.29 -7.32%

POET Technologies experienced a turbulent week, with its stock price declining 7.3% on Friday to close at $12.29. This drop contributed to a weekly loss of approximately 15.8% from the previous Friday's close of $14.59. Meanwhile, the Nasdaq Composite Index gained 2.4% over the same period, highlighting the contrasting performance of this AI optics play.

The company recently completed a registered direct offering, raising $400 million in gross proceeds. The deal involved the sale of 19,047,620 common shares and warrants for an equal number of shares at an exercise price of $26.25, placed directly with a single institutional investor. This capital infusion comes at a critical time as POET navigates multiple challenges.

CEO Suresh Venkatesan announced plans to expand wafer production and optical engine assembly capacity approximately tenfold to meet anticipated demand through 2027. The company now employs over 115 people globally and operates 20,000 square feet of assembly space in Malaysia. However, the market remains skeptical about whether this capacity will translate into sustained revenue growth.

POET's first-quarter 2025 financial results showed revenue of $503,389 and a net loss of $12.3 million. The company highlighted a recent $50 million order from Lumilens for EOI-based optical engines, which it described as an important commercial milestone, with potential cumulative sales exceeding $500 million over five years. Yet, the loss of a key customer has raised concerns.

On April 27, POET disclosed that Celestial AI, which was acquired by Marvell Technology, canceled all its purchase orders. Marvell claimed that POET's disclosure of purchase order details and shipping information violated confidentiality agreements. POET stated it continues to fulfill other customer orders, including one valued at approximately $5 million, but the uncertainty has weighed on investor sentiment.

Legal challenges persist. The Schall Law Firm reminded investors of a class-action lawsuit alleging violations of U.S. securities laws. Rosen Law Firm noted that buyers from April 1 to 8:57 a.m. ET on April 27 have until June 29 to seek lead-plaintiff status. A key issue in the case is POET's status as a Passive Foreign Investment Company (PFIC), which subjects U.S. investors to unfavorable tax treatment. POET plans to relocate its headquarters and re-domicile to the United States to eliminate PFIC risk in future years.

Short sellers have contributed to the stock's volatility. Dan David of Wolfpack Research told Business Insider that his firm views POET as one of several companies that 'don't make money, make a lot of promises, raise a lot of money.' Both POET and Marvell declined to comment on the report.

The competitive landscape is intensifying. Nvidia announced in March that it would invest $2 billion each in Lumentum and Coherent, two photonics suppliers, to secure optics for its AI chips. This has drawn attention to small-cap POET, though its revenue remains limited compared to these larger players.

Looking ahead, traders face a challenging setup. The stock is trading well below the $21 financing level, and while the company now has substantial cash reserves, the market is demanding tangible results. Key risks include delayed customer ramps, lingering concerns about Marvell, and ongoing legal and tax issues. For POET, a larger cash pile may not be enough if it cannot demonstrate that its optical engine roadmap will generate steady, repeat sales. Monday's opening price will provide an initial gauge of investor sentiment following a week of significant volatility.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →